Technology Transfer

TBD Pharmatech supports technology transfer of small-molecule APIs into EU cGMP manufacturing, including process adaptation, scale-up, and preparation for clinical or commercial production.

We enable the transition of API processes from laboratory development or external suppliers into controlled GMP manufacturing environments.

We provide

• Transfer of API processes into EU cGMP manufacturing facilities
• Process adaptation for GMP execution and scale-up
• Technical evaluation and optimisation of transferred processes
• Integration with analytical, quality, and regulatory systems
• Preparation for clinical and commercial API manufacturing

Technology transfer scope

• Transfer from laboratory-scale or pilot processes
• Transfer from external CDMOs or manufacturing partners
• Adaptation to EU cGMP production requirements
• Alignment with facility capabilities and batch scale (3–200 kg)

When to work with TBD Pharmatech

• When transferring API processes into EU GMP manufacturing
• When moving from development to clinical or commercial production
• When replacing or supplementing an existing manufacturing partner
• When scaling up processes for reliable GMP execution
• When working with niche or complex small-molecule APIs

Integration with CDMO and manufacturing services

Technology transfer is supported by integrated CDMO capabilities, including process development, scale-up, and GMP manufacturing. This ensures continuity from development through clinical and commercial API supply.